Literature DB >> 10889177

Commensal bacteria as targets in Crohn's disease.

C O Elson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10889177     DOI： 10.1053/gast.2000.9159

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  15 in total

Review 1.  Clinical aspects and pathophysiology of inflammatory bowel disease.

Authors:  Barbara A Hendrickson; Ranjana Gokhale; Judy H Cho
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

2.  The metabolic activity of fecal microbiota from healthy individuals and patients with inflammatory bowel disease.

Authors:  Marleen H M C van Nuenen; Koen Venema; Janneke C J van der Woude; Ernst J Kuipers
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

3.  T regulatory cells maintain intestinal homeostasis by suppressing γδ T cells.

Authors:  Sung-Gyoo Park; Ramkumar Mathur; Meixiao Long; Namiko Hosh; Liming Hao; Matthew S Hayden; Sankar Ghosh
Journal:  Immunity       Date:  2010-11-11       Impact factor: 31.745

Review 4.  Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications.

Authors:  J Mudter; M F Neurath
Journal:  Gut       Date:  2006-09-06       Impact factor: 23.059

5.  Complete genome sequence of Crohn's disease-associated adherent-invasive E. coli strain LF82.

Authors:  Sylvie Miquel; Eric Peyretaillade; Laurent Claret; Amélie de Vallée; Carole Dossat; Benoit Vacherie; El Hajji Zineb; Beatrice Segurens; Valerie Barbe; Pierre Sauvanet; Christel Neut; Jean-Frédéric Colombel; Claudine Medigue; Francisco J M Mojica; Pierre Peyret; Richard Bonnet; Arlette Darfeuille-Michaud
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

6.  IL-10 downregulates CXCR3 expression on Th1 cells and interferes with their migration to intestinal inflammatory sites.

Authors:  M Wadwa; R Klopfleisch; A Adamczyk; A Frede; E Pastille; K Mahnke; W Hansen; R Geffers; K S Lang; J Buer; J Büning; A M Westendorf
Journal:  Mucosal Immunol       Date:  2016-01-06       Impact factor: 7.313

Review 7.  Role of bacteria in the etiopathogenesis of inflammatory bowel disease.

Authors:  Nicolas Barnich; Arlette Darfeuille-Michaud
Journal:  World J Gastroenterol       Date:  2007-11-14       Impact factor: 5.742

8.  Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis.

Authors:  Michael Schultz; Ulrike G Strauch; Hans-Jörg Linde; Sonja Watzl; Florian Obermeier; Claudia Göttl; Nadja Dunger; Nicole Grunwald; Jürgen Schölmerich; Heiko C Rath
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

Review 9.  The gut microbiota shapes intestinal immune responses during health and disease.

Authors:  June L Round; Sarkis K Mazmanian
Journal:  Nat Rev Immunol       Date:  2009-05       Impact factor: 53.106

10.  The oxidoreductase DsbA plays a key role in the ability of the Crohn's disease-associated adherent-invasive Escherichia coli strain LF82 to resist macrophage killing.

Authors:  Marie-Agnès Bringer; Nathalie Rolhion; Anne-Lise Glasser; Arlette Darfeuille-Michaud
Journal:  J Bacteriol       Date:  2007-04-20       Impact factor: 3.490
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.